XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues        
Revenues $ 2,681 $ 2,510 $ 7,470 $ 7,066
Expenses        
Selling, general and administrative 795 850 2,556 2,476
Research and development 166 146 468 453
Amortization of intangible assets 253 274 765 818
Asset impairments 1 0 1 6
Restructuring, integration and separation costs 17 1 49 25
Other expense, net 80 225 77 245
Total expenses 2,062 2,192 6,131 6,078
Operating income 619 318 1,339 988
Interest income 15 7 39 24
Interest expense (412) (346) (1,207) (1,051)
Gain on extinguishment of debt 3 0 181 23
Foreign exchange and other (7) 0 (41) (26)
Income (loss) before income taxes 218 (21) 311 (42)
Provision for income taxes (37) (71) (88) (128)
Net income (loss) 181 (92) 223 (170)
Net (income) loss attributable to noncontrolling interest (2) 7 46 31
Net income (loss) attributable to Bausch Health Companies Inc. $ 179 $ (85) $ 269 $ (139)
Basic earnings (loss) per share attributable to Bausch Health Companies Inc. (in dollars per share) $ 0.48 $ (0.23) $ 0.73 $ (0.38)
Diluted earnings (loss) per share attributable to Bausch Health Companies Inc. (in dollars per share) $ 0.48 $ (0.23) $ 0.72 $ (0.38)
Basic weighted-average common shares (in shares) 371.3 368.4 370.6 367.7
Diluted weighted-average common shares (in shares) 375.5 368.4 374.1 367.7
Product sales        
Revenues        
Revenues $ 2,657 $ 2,482 $ 7,388 $ 6,990
Expenses        
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 735 682 2,166 2,018
Other revenues        
Revenues        
Revenues 24 28 82 76
Expenses        
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues $ 15 $ 14 $ 49 $ 37